Combination chemo-sirna gene therapy of nonmuscle-invading bladder cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43TR000356
- Recipient
-
Optimum Therapeutics, LLC UEI CAAGN783MMF1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $344,460
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- GRANDVIEW, OH 43212, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $344,460 |
Quick answers
Who received award R43TR000356?
R43TR000356 was awarded to Optimum Therapeutics, LLC by National Institutes of Health (Department of Health and Human Services) on September 8, 2012.
How much is award R43TR000356 worth?
$344,460 has been obligated on R43TR000356.
Which agency awarded R43TR000356?
National Institutes of Health (Department of Health and Human Services) awarded R43TR000356, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award